Cargando…
The effect of insulin administration on c-peptide in critically ill patients with type 2 diabetes
BACKGROUND: In critically ill patients with permissive hyperglycemia, it is uncertain whether exogenous insulin administration suppresses or enhances c-peptide secretion (a marker of pancreatic beta-cell response). We aimed to explore this effect in patients with type 2 diabetes. METHODS: We prospec...
Autores principales: | Crisman, Marco, Lucchetta, Luca, Luethi, Nora, Cioccari, Luca, Lam, Que, Eastwood, Glenn M., Bellomo, Rinaldo, Mårtensson, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Paris
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427062/ https://www.ncbi.nlm.nih.gov/pubmed/28497374 http://dx.doi.org/10.1186/s13613-017-0274-5 |
Ejemplares similares
-
Prevalence of ketosis, ketonuria, and ketoacidosis during liberal glycemic control in critically ill patients with diabetes: an observational study
por: Luethi, Nora, et al.
Publicado: (2016) -
Nature and impact of in-hospital complications associated with persistent critical illness
por: Tseitkin, Boris, et al.
Publicado: (2023) -
Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine
por: Cioccari, Luca, et al.
Publicado: (2020) -
Sodium glucose co-transporter-2 inhibitors in intensive care unit patients with type 2 diabetes: a pilot case control study
por: Mårtensson, Johan, et al.
Publicado: (2023) -
Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation
por: Jones, Sarah L., et al.
Publicado: (2015)